Format

Send to

Choose Destination
Neuropsychopharmacology. 2016 Mar;41(4):1128-37. doi: 10.1038/npp.2015.253. Epub 2015 Aug 20.

Corticostriatal Afferents Modulate Responsiveness to Psychostimulant Drugs and Drug-Associated Stimuli.

Author information

1
Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
2
Neuroscience Graduate Program, University of Washington, Seattle, WA, USA.
3
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
4
Department of Pharmacology, University of Washington, Seattle, WA, USA.

Abstract

The medial prefrontal cortex (mPFC) and nucleus accumbens (NAc) are both integral components of the corticobasal ganglia-thalamic circuitry that regulates addiction-related behaviors. However, the role of afferent inputs from mPFC to NAc in these behaviors is unclear. To address this, we used a Cre-recombinase-dependent viral vector approach to express G(i/o)-coupled DREADDs (designer receptors exclusively activated by designer drugs) selectively in mPFC neurons projecting to the NAc and examined the consequences of attenuating activity of these neurons on the induction of amphetamine sensitization and on drug taking and drug seeking during cocaine self-administration. Surprisingly, decreasing mPFC afferent activity to the NAc only transiently reduced locomotor sensitization and had no effect on drug taking during cocaine self-administration. However, inhibiting corticostriatal afferent activity during sensitization subsequently enhanced conditioned responding. In addition, this manipulation during drug self-administration resulted in slower rates of extinction and increased responding during drug prime-induced reinstatement-an effect that was normalized by inhibiting these corticostriatal afferents immediately before the drug prime. These results suggest that dampening cortical control over the NAc during drug exposure may lead to long-term changes in the ability of drugs and associated stimuli to drive behavior that has important implications for guiding treatments to prevent relapse.

PMID:
26289144
PMCID:
PMC4748437
[Available on 2017-03-01]
DOI:
10.1038/npp.2015.253
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center